icon-folder.gif   Conference Reports for NATAP  
  The Liver Meeting
Boston MA
November 2019
Back grey_arrow_rt.gif
Higher Number of Concurrent Metabolic Co-Morbidities Is Associated with Increasingly Higher Risk of Significant Hepatic Fibrosis and Cirrhosis in Nonalcoholic Fatty Liver Disease Patients
  AASLD 2019 Nov 8-12 Boston
Reported by Jules Levin
Robert J. Wong, M.D., M.S., Tram T. Tran, M.D., Harvey Kaufman, M.D., Justin Niles, M.A., Robert Gish, M.D.
Division of Gastroenterology and Hepatology, Alameda Health System - Highland Hospital, Oakland, CA; Gilead Sciences, Foster City, CA; Quest Diagnostics, Secaucus, NJ; Hepatitis B Foundation]






Wong RJ, Tran T, Kaufman H, Niles J, Gish R. Increasing metabolic co-morbidities are associated with higher risk of advanced fibrosis in nonalcoholic steatohepatitis. PLoS One. 2019;14(8):e0220612.
Kabbany MN, Conjeevaram Selvakumar PK, Watt K, Lopez R, Akras Z, Zein N, Carey W, Alkhouri N. Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data. Am J Gastroenterol. 2017 Apr;112(4):581-587